| [1]FOLEY R N,PARFREY P S,SARNAK M J.Clinical epidemiology of cardiovascular disease in chronic renal disease[J].Am J Kidney Dis,1998,32(5 Suppl 3):S112-119.
[2]PUN P H,LEHRICH R W,HONEYCUTT E F,et al.Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics[J].Kidney Int,2011,79(2):218-227.
[3] UNITED STATES RENAL DATA SYSTEM.Annual data report:reference tables[EB/OL].[2016-08-01].http://www.usrds.org/reference.aspx.
[4]SACCHETTI A,STUCCIO N,PANEBIANCO P,et al.ED hemodialysis for treatment of renal failure emergencies[J].Am J Emerg Med,1999,17(3):305-307.
[5]杨月欣.中国食物成分表第二版[M].北京:北京大学医学出版社,2009.
[6]The Royal Children’s Hospital Melbourne.Resuscitation clinical practical guidelines[EB/OL].(2016-03-02)[2016-04-12].http://www.rch.org.au/clinicalguide/guideline_index/Hyperkalaemia/.
[7]AHMED J,WEISBERG L S.Hyperkalemia in dialysis patients[J].Semin Dial,2001,14(5):348-356.
[8]WEISBERG L S.Management of severe hyperkalemia[J].Crit Care Med,2008,36(12):3246-3251.
[9]NGUGI N,MCLIGEYO S O,KAYIMA J K.Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure:effect of various therapeutic approaches[J].East Afr Med J,1997,74(8):503-509.
[10]BUEMI M,ALOISI E,COPPOLINO G,et al.The effect of two different protocols of potassium haemodiafiltration on QT dispersion[J].Nephrol Dial Transplant,2005,20(6):1148-1154.
[11]BLEYER A J,HARTMAN J,BRANNON P C,et al.Characteristics of sudden death in hemodialysis patients[J].Kidney Int,2006,69(12):2268-2273.
[12]NELMS M N,SUCHER K P,LACEY K,et al.Nutrition Therapy and Pathophysiology[M].2nd Edition.Nelms:Cengage Learning,2010.
[13]PANI A,FLORIS M,ROSNER MH,et al.Hyperkalemia in hemodialysis patients[J].Semin Dial,2014,27(6):571-576.
[14]DE NICOLA L,BELLIZZI V,MINUTOLO R,et al.Effect of dialysate sodium concentration on interdialytic increase of potassium[J].J Am Soc Nephrol,2000,11(12):2337-2343.
[15]SANGHAVI S,WHITING S,URIBARRI J.Potassium balance in dialysis patients[J].Semin Dial,2013,26(5):597-603.
[16]ZEHNDER C,GUTZWILLER J P,HUBER A,et al.Lowpotassium and glucose-free dialysis maintains urea but enhances potassium removal[J].Nephrol Dial Transplant,2001,16(1):78-84.
[17]KOVESDY CP,REGIDOR DL,MEHROTRA R,et al.Serum and dialysate potassium concentrations and survival in hemodialysis patients[J].Clin J Am Soc Nephrol,2007,2(5):999-1007.
[18]BARRY M BRENNER.Brenner and rector’s the kidney[M].Philadelphia:W.B.Saunders,2008.
[19]PUN P H,LEHRICH R W,HONEYCUTT E F,et al.Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics[J].Kidney Int,2011,79(2):218-227.
[20]JADOUL M,THUMMA J,FULLER D S,et al.Modifiable practices associated with sudden death among hemodialysis patients in the dialysis outcomes and practice patterns study[J].Clin J Am Soc Nephrol,2012,7(5):765-774.
[21]MUNOZ R I,MONTENEGRO J,SALCEDO A,et al.Effect of acetate-free biofiltration with a potassium-profiled dialysate on the control of cardiac arrhythmias in patients at risk:a pilot study[J].Hemodial Int,2008,12(1):108-113.
[22]BLUMBERG A,ROSER H W,ZEHNDER C,et al.Plasma potassium in patients with terminal renal failure during and after haemodialysis:relationship with dialytic potassium removal and total body potassium[J].Nephrol Dial Transplant,1997,12(8):1629-1634.
[23]NEPAL M,BUCALOIU I D,NORFOLK E R.Hypernatremia in a patient treated with sodium polystyrene sulfonate[J].Int J Nephrol Renovasc Dis,2010,3:141-143.
[24]WAKABAYASHI M,SHOU I,SATAKE K,et al.Study on the dose response of a jelly preparation of polystyrene sulfonate calcium in hyperkalemia[J].Ther Res,2005,26:1727-1733.
[25]CHAABAN A,ABOUCHACRA S,GEBRAN N,et al.Potassium binders in hemodialysis patients:a friend or foe?[J] .Ren Fail,2013,35(2):185-188.
[26]TOMINO Y,YAMAZAKI T,SHOU I,et al.Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia——changes in serum potassium levels with or without a RAAS inhibitor[J].Clin Nephrol,2007,68(6):379-385. |